Home › Pituitary Dwarfism › District of Columbia › Washington
Pituitary Dwarfism clinical trials in Washington, DC
4 studies for Pituitary Dwarfism are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
RecruitingPhase 3
- Lumos Pharma Investigational Site, Washington D.C.
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
RecruitingPhase 3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
RecruitingObservational study
- Ascendis Investigational Site, Washington D.C.
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
RecruitingObservational study
- Ascendis Investigational Site, Washington D.C.
Pituitary Dwarfism trials in other cities
- Seattle, WA5 studies
- Minneapolis, MN4 studies
- Columbia, SC3 studies
- Indianapolis, IN3 studies
- Orange, CA3 studies
- Dallas, TX3 studies
- Cedar Rapids, IA3 studies
- Las Vegas, NV3 studies
- Sacramento, CA3 studies
- Centennial, CO3 studies
- Orlando, FL3 studies
- Phoenix, AZ3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.